Evidence map›Paper›PMID 28844103›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2017

The Mla pathway is critical for Pseudomonas aeruginosa resistance to outer membrane permeabilization and host innate immune clearance.

Jason Munguia, Doris L LaRock, Hannah Tsunemoto, Joshua Olson, Ingrid Cornax, Joseph Pogliano, Victor Nizet

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. ThemBio · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in microbiology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. A periplasmic phospholipase that maintains outer membrane lipid asymmetry inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Anti-Microorganisms · 2023
    Review
  14. Review
  15. Article
  16. Experimental evolution ofFrontiers in microbiology · 2022
    Article
  17. Genetic Basis of High-Pressure Tolerance of aFrontiers in microbiology · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jason MunguiaDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Doris L LaRockDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Hannah TsunemotoDivision of Biological Sciences, University of California San Diego, La Jolla, CA, USA.
Joshua OlsonDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Ingrid CornaxDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Joseph PoglianoDivision of Biological Sciences, University of California San Diego, La Jolla, CA, USA.
Victor NizetDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA. vnizet@ucsd.edu.ORCID 0000-0003-3847-0422
University of California San Diego · US

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Systems Biology Approach to Redefine Susceptibility Testing and Treatment of MDR Pathogens in the Context of Host ImmunityU01AI124316 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PALSSON, BERNHARD O · 2016 to 2020
$10.2M
Cathelicidins in Skin ImmunityR01AI052453 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L, NIZET, VICTOR · 2002 to 2017
$5.3M
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant InfectionsR01AI093451 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOHNSON, RANDALL SCOTT, NIZET, VICTOR · 2011 to 2015
$4.9M
Cathelicidin in Skin ImmunityR37AI052453 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Richard L Gallo, Victor Nizet · 2019 to 2026
$4.6M
Safety and Dose Optimization of High-Dose Anakinra in Kawasaki DiseaseU54HD090259 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIGAM, SANJAY K · 2016 to 2018
$2.2M
Training in Respiratory Biology: Innovate, Integrate, and TranslateT32HL098062 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI POWELL, FRANK L. · 2010 to 2014
$2.1M
UCSD Research Training Program for VeterinariansT32OD017863 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ERNST, PETER B., SIGURDSON, CHRISTINA · 2014 to 2023
$2.0M
Safety and Dose Optimization of High-Dose Anakinra in Kawasaki DiseaseP50HD090259 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CAPPARELLI, EDMUND VINCENT, NIZET, VICTOR · 2019 to 2020
$1.4M
NHLBI NIH HHS T32 HL098062NIAID NIH HHS R01 AI052453NIAID NIH HHS R01 AI093451NIAID NIH HHS R37 AI052453NIAID NIH HHS U01 AI124316NICHD NIH HHS P50 HD090259NICHD NIH HHS U54 HD090259NIGMS NIH HHS T32 GM007752NIH HHS T32 OD017863
6 · The paper itself

Abstract

Pseudomonas aeruginosa is an important opportunistic pathogen that has become a serious problem due to increased rates of antibiotic resistance. Due to this along with a dearth in novel antibiotic development, especially against Gram-negative pathogens, new therapeutic strategies are needed to prevent a post-antibiotic era. Here, we describe the importance of the vacJ/Mla pathway in resisting bactericidal actions of the host innate immune response. P. aeruginosa tn5 transposon mutants in genes from the VacJ/Mla pathway showed increased susceptibility to killing by the host cathelicidin antimicrobial peptide, LL-37, when compared to the wild-type parent strain. The P. aeruginosa vacJ KEY MESSAGES: • The Mla pathway regulates outer membrane dynamics in human pathogen Pseudomonas aeruginosa (PA). • Disruption of Mla pathway gene vacJ sensitizes PA to host cathelicidin antimicrobial peptide LL-37. • Loss of vacJ expression renders PA more sensitive to human whole blood and serum killing. • Loss of vacJ expression reduces PA survival and virulence in a murine lung infection model. • The Mla pathway merits exploration as a pharmacologic target to sensitize PA to host innate immunity.

Indexed as

Immunity, InnateSignal TransductionAnimalsAntimicrobial Cationic PeptidesBacterial Outer Membrane ProteinsCathelicidinsFemaleGene DeletionHumansMice, Inbred C57BLPseudomonas aeruginosaPseudomonas InfectionsAntimicrobial Cationic PeptidesBacterial Outer Membrane ProteinsCathelicidinsAntimicrobial peptideCathelicidinInnate immunityMla pathwayPneumoniaPseudomonas aeruginosa

Identifiers

PMID28844103
PMCPMC5671890
OpenAlexW2746388040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.